1 week ago 7

News24 | Zimbali Estate and resident head to court in defamation, intimidation and R700 000 levy bill battle

Share this via

A battle involving allegations of defamation, intimidation, harassment and a R700 000 levy bill between a resident of the luxury coastal estate of Zimbali in Durban and its board CEO has ended up in court.
Read Entire Article
  1. Homepage
  2. Headlines
  3. News24 | Zimbali Estate and resident head to court in defamation, intimidation and R700 000 levy bill battle

From Twitter

Related

College basketball team evacuates bus before it goes up in flames on highway

College basketball team evacuates bus before it goes up in f...

30 minutes ago 0
Noem ends Biden-era use of controversial app to allow migrants to board flights, except to self-deport

Noem ends Biden-era use of controversial app to allow migran...

35 minutes ago 0
Top federal agency takes DOGE's mission to heart with all-hands memo to every employee: 'Reduction in force'

Top federal agency takes DOGE's mission to heart with all-ha...

44 minutes ago 0
Ramaswamy officially launches gubernatorial campaign in Ohio: 'Best days are still yet ahead'

Ramaswamy officially launches gubernatorial campaign in Ohio...

49 minutes ago 0

Comments

Trending

1. Al Trautwig
2. Apple Stock
3. Harrison Ford
4. Nvidia stock
5. Oscars
6. Meta stock
7. Palantir stock
8. Lester Holt
9. S&P 500
10. Roberta Flack

Popular News

Trump administration fires more than a dozen immigration jud...
1 week ago
Trump administration fires more than a dozen immigration judges

Hamas hands over three Israeli captives in sixth phase of pr...
1 week ago
Hamas hands over three Israeli captives in sixth phase of prisoner exchange

Why has a former Tory MP decide to serve in Ukraine’s milita...
1 week ago
Why has a former Tory MP decide to serve in Ukraine’s military? | BBC News

'Cobra Kai' is a rare show that kids and adults both enjoy: ...
1 week ago
'Cobra Kai' is a rare show that kids and adults both enjoy: 'That's the really cool thing about' the series, its co-creator says

ASCO GU｜RemeGen Announced Highly Encouraging Data from the P...
1 week ago
ASCO GU｜RemeGen Announced Highly Encouraging Data from the Phase II Clinical Trial Evaluating Disitamab Vedotin plus Immunotherapy as Perioperative Regimen for Bladder Cancer
About Us · Contact Us · Terms & Conditions · Help · Privacy ·

© Latest News Search Engine - Global and Local Breaking News 2025. All rights are reserved